Wednesday, March 16, 2016

Bioethics of Cognitive Drugs for Down Syndrome

"Ally’s story, and Penny’s story, don’t negate the significance of these new neurological findings, or the fact that drug interventions for cognition will come as good news for some people with Down syndrome. I am not certain that Penny needs medical interventions to improve her cognition, but I know she needs a social context that welcomes her."

Amy Julia Becker on the ethics of a "pill for Down syndrome," in The Atlantic.

I think about these issues all the time. There's a major trial going on in Chicago, in which we are not participating, but Nico frequently reveals frustration at his communication delays. If a pill could help him through those, I'm pretty sure he'd consent to it.

No comments: